Jacob Smith

• Science & Technology

Stopping the spread: A revolution in how we think about metastasis

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

18 October 2022

• Science & Technology

How “the most advanced machine learning approach” is finding new cancer-causing mutational signatures

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

12 October 2022

• Health & Medicine

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

13 September 2022

• Science & Technology

Scientists reveal how air pollution can cause lung cancer in people who have never smoked

A long-term study funded by Cancer Research UK has revealed how air pollution can cause lung cancer in people who have never smoked.  A long-term study funded by Cancer Research UK has revealed how air pollution can cause lung cancer in people who have never smoked. 

10 September 2022

• Policy & Insight

Speaking for Scotland: What our Scottish Campaigns Ambassadors want in a 10-Year Cancer Plan 

We hear from four of our Campaigns Ambassadors in Scotland about what they want to see in a new, comprehensive 10-Year Cancer Plan We hear from four of our Campaigns Ambassadors in Scotland about what they want to see in a new, comprehensive 10-Year Cancer Plan

24 August 2022

• Science & Technology
• Health & Medicine

How we can reduce cancer risk in inflammatory bowel disease patients by blocking a Hedgehog

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.  If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

23 August 2022

• Health & Medicine

Help seeking: Why isn’t it as simple as it might sound?

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it? A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

10 August 2022

• Health & Medicine

A Cancer Revolution: What the experts think of the new Science Museum exhibition

We spoke to Dr Vivian Li and Rupal Mistry about their thoughts on the Cancer Revolution exhibition at the Science Museum. We spoke to Dr Vivian Li and Rupal Mistry about their thoughts on the Cancer Revolution exhibition at the Science Museum.

25 July 2022

• Health & Medicine

Closing the gap: How new screening interventions could reduce inequalities in bowel cancer outcomes

If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.   If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.  

5 July 2022

• Health & Medicine
• Science & Technology

How erectile dysfunction drugs could be the key to overcoming treatment resistance in oesophageal cancer

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect.  Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

21 June 2022